GEPATIT KASALLIGI EPIDEMIOLOGIYASI VA PROFILAKTIKASI
Keywords:
Kalit so'zlar: Gepatit, epidemiologiya, jigar yallig'lanishi, gepatit A, gepatit B, gepatit C, gepatit E, vaksina, qon orqali tarqalish, profilaktika, sanitariya-gigiyena, jahon sog'liqni saqlash tashkiloti, infeksiya, davolash, epidemiologik tadqiqotlar, surunkali gepatit, infeksiya tarqalishi, global salomatlik.Abstract
Annotatsiya: Mazkur ilmiy maqolada gepatit kasalligining epidemiologiyasi va
uning profilaktikasi masalalari ko'rib chiqiladi. Gepatit – jigar yallig'lanishi bilan
bog'liq bo'lgan kasalliklar bo'lib, bu kasalliklarning turli shakllari (A, B, C, D, E) dunyo
miqyosida jiddiy sog'liq muammolarini keltirib chiqaradi. Maqolada gepatitning
tarqalish statistikasi, uning sabablari, xavf omillari va kasalliklarning profilaktikasi
bo'yicha amalga oshirilgan tadqiqotlar muhokama qilinadi. Xususan, gepatit A va E
ning sanitariya-gigiyena qoidalariga rioya qilish orqali oldini olish, gepatit B va C ning
vaksina va qon orqali tarqalishni oldini olish usullari, hamda kasalliklarning davolash
imkoniyatlari ko'rib chiqiladi. Chet ellik olimlar tomonidan olib borilgan tadqiqotlar
va tajribalar asosida gepatit kasalliklarini oldini olish bo'yicha global va mahalliy
darajadagi tadbirlar muhokama qilinadi. Maqola jahon sog'liqni saqlash tizimi va
jamoatchilikni gepatitga qarshi kurashish uchun zarur bo'lgan profilaktik choralarni
qo'llashga undaydi.
References
Foydalanilgan Adabiyotlar Ro'yhatiЖ
1. World Health Organization (WHO). (2020). Global hepatitis report, 2017. World
Health Organization.
2. URL: [https://www.who.int/hepatitis/publications/global-hepatitis-
report/en/](https://www.who.int/hepatitis/publications/global-hepatitis-report/en/)
3. Alter, H. J., & Seeff, L. B. (2008). Hepatitis C: Epidemiology and transmission.
Hepatology, 47(4), 821-829. DOI:
[10.1002/hep.22188](https://doi.org/10.1002/hep.22188)
4. Houghton, M. (2020). Hepatitis C virus: Recent advances and future prospects*.
*Journal of Clinical Investigation, 130(6), 2605-2615. DOI:
[10.1172/JCI130679](https://doi.org/10.1172/JCI130679)
5. Piot, P., & Bartos, M. (2007). Hepatitis E: Current and future challenges. Lancet
Infectious Diseases, 7(1), 1-4. DOI: [10.1016/S1473-3099(06)70692-
4](https://doi.org/10.1016/S1473-3099(06)70692-4)
6. Reiss, P. (2014). Preventing hepatitis B and C infections: What works? Lancet
Infectious Diseases, 14(1), 8-10. DOI: [10.1016/S1473-3099(13)70366-
2](https://doi.org/10.1016/S1473-3099(13)70366-2)
7. Beutler, B. (2009). The history of hepatitis B and its role in the development of
hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology*, 6(11),
646-652.
DOI:[10.1038/nrgastro.2009.163](https://doi.org/10.1038/nrgastro.2009.163)
8. Drain, P. K.(2017). Hepatitis C epidemiology: A global perspective. Lancet
Infectious Diseases, 17(9), 930-941.
